RAPID MICRO BIOSYSTEMS, INC. — Regulatory Filings 2021

Jul 12, 2021

8-A12B 1 tm219739d13_8a12b.htm 8-A12B

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

FORM 8-A

Field: Rule-Page

Field: /Rule-Page

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF

THE SECURITIES EXCHANGE ACT OF 1934

Field: Rule-Page

Field: /Rule-Page

Rapid Micro Biosystems, Inc.

(Exact name of registrant as specified in its charter)

Field: Rule-Page

Field: /Rule-Page

Delaware	20-8121647
(State of incorporation or organization)	(I.R.S. Employer Identification No.)
1001 Pawtucket Boulevard West, Suite 280 Lowell, MA 01854	01854
(Address of principal executive offices)	(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

| Title of each class to be so registered | Name of each exchange on which each class is to be registered | | --- | --- | | Class A Common Stock, $0.01 par value per share | The Nasdaq Stock Market LLC |

Field: Rule-Page

Field: /Rule-Page

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c) or (e), check the following box. x

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d) or (e), check the following box. ¨

If this form relates to the registration of a class of securities concurrently with a Regulation A offering, check the following box. ¨

Securities Act registration statement or Regulation A offering statement file number to which this form relates: 333-257431

Securities to be registered pursuant to Section 12(g) of the Act: None .

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

ITEM 1. Description of Registrant’s Securities to be Registered.

The description of the Class A Common Stock, par value $0.01 per share, of Rapid Micro Biosystems, Inc. (the “ Registrant ”) under the heading “Description of Capital Stock” in the prospectus included in the Registrant’s Registration Statement on Form S-1 (File No. 333-257431) , as initially filed with the Securities and Exchange Commission on June 25, 2021, including exhibits, and as may be subsequently amended (the “ Registration Statement ”), is hereby incorporated by reference. Any form of prospectus that constitutes part of the Registration Statement and is subsequently filed by the Registrant pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be deemed to be incorporated by reference herein.

ITEM 2. Exhibits.

Pursuant to the Instructions as to Exhibits for Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The Nasdaq Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.

Field: Page; Sequence: 2

Field: /Page

SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: July 12, 2021

RAPID MICRO BIOSYSTEMS, INC.
By:	/s/ Robert Spignesi
	Robert Spignesi
	President and Chief Executive Officer

Field: Page; Sequence: 3; Options: Last

Field: /Page